Performance of 111In-labelled PSMA ligand in patients with nodal metastatic prostate cancer: correlation between tracer uptake and histopathology from lymphadenectomy.
Michael MixKathrin ReichelChristian StoykowMark BartholomäVanessa DrendelEleni GourniUlrich WetterauerWolfgang Schultze-SeemannPhilipp T MeyerCordula A JilgPublished in: European journal of nuclear medicine and molecular imaging (2018)
Ex situ analysis at the level of single LN showed that 111In-PSMA-617 had excellent ability to discriminate between affected and nonaffected LN in our patients with PCa. This tracer characteristic is a prerequisite for in vivo real-time measurements during surgery.
Keyphrases
- pet imaging
- prostate cancer
- pet ct
- positron emission tomography
- lymph node
- minimally invasive
- squamous cell carcinoma
- small cell lung cancer
- radical prostatectomy
- coronary artery bypass
- early stage
- neoadjuvant chemotherapy
- sentinel lymph node
- lymph node metastasis
- computed tomography
- robot assisted
- acute coronary syndrome
- atrial fibrillation
- coronary artery disease
- data analysis